Asialoglycoprotein receptor (ASGPR): A peculiar target of liver-specific autoimmunity

Autoimmunity Highlights

Volumn 3, Issue 3, 2012, Pages 119-125

  Roggenbuck, Dirk ^a,b   Mytilinaiou, Maria G ^c   Lapin, Sergey V ^d   Reinhold, Dirk ^e   Conrad, Karsten ^f  

^a UNIVERSITY OF APPLIED SCIENCES   (Germany)

^b GA GENERIC ASSAYS GMBH   (Germany)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

^e OTTO VON GUERICKE UNIVERSITY   (Germany)

^f DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Autoantibody; Autoimmune hepatitis; Autoimmunity; Liver disease; Primary biliary cirrhosis

Indexed keywords

ANTILIVER KIDNEY MICROSOMAL 1 ANTIBODY; ANTINUCLEAR ANTIBODY; ASIALOGLYCOPROTEIN RECEPTOR; ASIALOGLYCOPROTEIN RECEPTOR ANTIBODY; AUTOANTIGEN; MICROSOME ANTIBODY; RECEPTOR ANTIBODY; SMOOTH MUSCLE ANTIBODY; UNCLASSIFIED DRUG;

AUTOIMMUNE HEPATITIS; AUTOIMMUNE LIVER DISEASE; AUTOIMMUNITY; CELL ACTIVITY; CELL LOSS; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE MARKER; HEPATITIS; HUMAN; IMMUNOASSAY; IMMUNOPRECIPITATION; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE;

EID: 84870515227     PISSN: 20380305     EISSN: 20383274     Source Type: Journal    
DOI: 10.1007/s13317-012-0041-4     Document Type: Review

References (104)

1. Ashwell G, Morell AG (1974) The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. Adv Enzymol Relat Areas Mol Biol 41: 99-128.
2. Ashwell G, Harford J (1982) Carbohydrate-specific receptors of the liver. Annu Rev Biochem 51: 531-554.
3. Morell AG, Gregoriadis G, Scheinberg IH et al (1971) The role of sialic acid in determining the survival of glycoproteins in the circulation. J Biol Chem 246: 1461-1467.
4. Morell AG, Irvine RA, Sternlieb I et al (1968) Physical and chemical studies on ceruloplasmin. V. Metabolic studies on sialic acid-free ceruloplasmin in vivo. J Biol Chem 243: 155-159.
5. Drickamer K (1988) Two distinct classes of carbohydrate-recognition domains in animal lectins. J Biol Chem 263: 9557-9560.
6. Drickamer K (1996) Ca(2+)-dependent sugar recognition by animal lectins. Biochem Soc Trans 24: 146-150.
7. Anonymous (2008) Gilbert Ashwell: sweet on science. Nat Med 14: 608.
8. Morell AG, van den Hamer CJ, Scheinberg IH et al (1966) Physical and chemical studies on ceruloplasmin. IV. Preparation of radioactive, sialic acid-free ceruloplasmin labeled with tritium on terminal d-galactose residues. J Biol Chem 241: 3745-3749.
9. van Den Hamer CJ, Morell AG, Scheinberg IH et al (1970) Physical and chemical studies on ceruloplasmin. IX. The role of galactosyl residues in the clearance of ceruloplasmin from the circulation. J Biol Chem 245: 4397-4402.
10. Baenziger J, Kornfeld S (1974) Structure of the carbohydrate units of IgA1 immunoglobulin. II. Structure of the O-glycosidically linked oligosaccharide units. J Biol Chem 249: 7270-7281.
11. Spiess M (1990) The asialoglycoprotein receptor: a model for endocytic transport receptors. Biochemistry 29: 10009-10018.
12. Stockert RJ (1995) The asialoglycoprotein receptor: relationships between structure, function, and expression. Physiol Rev 75: 591-609.
13. Diao J, Michalak TI (1996) Composition, antigenic properties and hepatocyte surface expression of the woodchuck asialoglycoprotein receptor. J Recept Signal Transduct Res 16: 243-271.
14. Pricer WE Jr, Hudgin RL, Ashwell G et al (1974) A membrane receptor protein for asialoglycoproteins. Methods Enzymol 34: 688-691.
15. Weigel PH (1980) Characterization of the asialoglycoprotein receptor on isolated rat hepatocytes. J Biol Chem 255: 6111-6120.
16. Lee YC, Townsend RR, Hardy MR et al (1983) Binding of synthetic oligosaccharides to the hepatic Gal/GalNAc lectin. Dependence on fine structural features. J Biol Chem 258: 199-202.
17. Hardy MR, Townsend RR, Parkhurst SM et al (1985) Different modes of ligand binding to the hepatic galactose/N-acetylgalactosamine lectin on the surface of rabbit hepatocytes. Biochemistry 24: 22-28.
18. Chiu MH, Tamura T, Wadhwa MS et al (1994) In vivo targeting function of N-linked oligosaccharides with terminating galactose and N-acetylgalactosamine residues. J Biol Chem 269: 16195-16202.
19. Breitfeld PP, Rup D, Schwartz AL (1984) Influence of the N-linked oligosaccharides on the biosynthesis, intracellular routing, and function of the human asialoglycoprotein receptor. J Biol Chem 259: 10414-10421.
20. Stockert RJ, Kressner MS, Collins JC et al (1982) IgA interaction with the asialoglycoprotein receptor. Proc Natl Acad Sci USA 79: 6229-6231.
21. Daniels CK, Schmucker DL, Jones AL (1989) Hepatic asialoglycoprotein receptor-mediated binding of human polymeric immunoglobulin A. Hepatology 9: 229-234.
22. Tomana M, Kulhavy R, Mestecky J (1988) Receptor-mediated binding and uptake of immunoglobulin A by human liver. Gastroenterology 94: 762-770.
23. Rifai A, Fadden K, Morrison SL et al (2000) The N-glycans determine the differential blood clearance and hepatic uptake of human immunoglobulin (Ig)A1 and IgA2 isotypes. J Exp Med 191: 2171-2182.
24. Baenziger J, Kornfeld S (1974) Structure of the carbohydrate units of IgA1 immunoglobulin. I. Composition, glycopeptide isolation, and structure of the asparagine-linked oligosaccharide units. J Biol Chem 249: 7260-7269.
25. Inamoto T, Brown WR (1991) IgG is associated with the asialoglycoprotein receptor in the human liver. Hepatology 14: 1070-1075.
26. Windler E, Greeve J, Levkau B et al (1991) The human asialoglycoprotein receptor is a possible binding site for low-density lipoproteins and chylomicron remnants. Biochem J 276(Pt 1): 79-87.
27. Ishibashi S, Perrey S, Chen Z et al (1996) Role of the low density lipoprotein (LDL) receptor pathway in the metabolism of chylomicron remnants. A quantitative study in knockout mice lacking the LDL receptor, apolipoprotein E, or both. J Biol Chem 271: 22422-22427.
28. Rotundo RF, Vincent PA, McKeown-Longo PJ et al (1999) Hepatic fibronectin matrix turnover in rats: involvement of the asialoglycoprotein receptor. Am J Physiol 277: G1189-G1199.
29. Yang J, Bo XC, Ding XR et al (2006) Antisense oligonucleotides targeted against asialoglycoprotein receptor 1 block human hepatitis B virus replication. J Viral Hepat 13: 158-165.
30. Yang J, Wang F, Tian L et al (2010) Fibronectin and asialoglyprotein receptor mediate hepatitis B surface antigen binding to the cell surface. Arch Virol 155: 881-888.
31. Treichel U, Meyer zum Buschenfelde KH, Dienes HP (1997) Receptor-mediated entry of hepatitis B virus particles into liver cells. Arch Virol 142: 493-498.
32. Treichel U, Meyer zum Buschenfelde KH, Stockert RJ et al (1994) The asialoglycoprotein receptor mediates hepatic binding and uptake of natural hepatitis B virus particles derived from viraemic carriers. J Gen Virol 75(Pt 11): 3021-3029.
33. Dotzauer A, Gebhardt U, Bieback K et al (2000) Hepatitis A virus-specific immunoglobulin A mediates infection of hepatocytes with hepatitis A virus via the asialoglycoprotein receptor. J Virol 74: 10950-10957.
34. Wu GY, Wu CH (1988) Receptor-mediated gene delivery and expression in vivo. J Biol Chem 263: 14621-14624.
35. Wu GY, Zhan P, Sze LL et al (1994) Incorporation of adenovirus into a ligand-based DNA carrier system results in retention of original receptor specificity and enhances targeted gene expression. J Biol Chem 269: 11542-11546.
36. Marth JD, Grewal PK (2008) Mammalian glycosylation in immunity. Nat Rev Immunol 8: 874-887.
37. Guy CS, Rankin SL, Michalak TI (2011) Hepatocyte cytotoxicity is facilitated by asialoglycoprotein receptor. Hepatology 54: 1043-1050.
38. Huang L, Soldevila G, Leeker M et al (1994) The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo. Immunity 1: 741-749.
39. Huang L, Sye K, Crispe IN (1994) Proliferation and apoptosis of B220+CD4-CD8-TCR alpha beta intermediate T cells in the liver of normal adult mice: implication for lpr pathogenesis. Int Immunol 6: 533-540.
40. Grewal PK, Uchiyama S, Ditto D et al (2008) The Ashwell receptor mitigates the lethal coagulopathy of sepsis. Nat Med 14: 648-655.
41. Rumjantseva V, Grewal PK, Wandall HH et al (2009) Dual roles for hepatic lectin receptors in the clearance of chilled platelets. Nat Med 15: 1273-1280.
42. Grewal PK (2010) The Ashwell-Morell receptor. Methods Enzymol 479: 223-241.
43. Sorensen AL, Rumjantseva V, Nayeb-Hashemi S et al (2009) Role of sialic acid for platelet life span: exposure of beta-galactose results in the rapid clearance of platelets from the circulation by asialoglycoprotein receptor-expressing liver macrophages and hepatocytes. Blood 114: 1645-1654.
44. Becker S, Spiess M, Klenk HD (1995) The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus. J Gen Virol 76(Pt 2): 393-399.
45. Burgess JB, Baenziger JU, Brown WR (1992) Abnormal surface distribution of the human asialoglycoprotein receptor in cirrhosis. Hepatology 15: 702-706.
46. Nakaya R, Kohgo Y, Mogi Y et al (1994) Regulation of asialoglycoprotein receptor synthesis by inflammation-related cytokines in HepG2 cells. J Gastroenterol 29: 24-30.
47. Treichel U, Paietta E, Poralla T et al (1994) Effects of cytokines on synthesis and function of the hepatic asialoglycoprotein receptor. J Cell Physiol 158: 527-534.
48. Marshall JS, Green AM, Pensky J et al (1974) Measurement of circulating desialylated glycoproteins and correlation with hepatocellular damage. J Clin Invest 54: 555-562.
49. Poralla T, Treichel U, Lohr H et al (1991) The asialoglycoprotein receptor as target structure in autoimmune liver diseases. Semin Liver Dis 11: 215-222.
50. Jensen DM, McFarlane IG, Portmann BS et al (1978) Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis. N Engl J Med 299: 1-7.
51. McFarlane IG, McFarlane BM, Major GN et al (1984) Identification of the hepatic asialo-glycoprotein receptor (hepatic lectin) as a component of liver specific membrane lipoprotein (LSP). Clin Exp Immunol 55: 347-354.
52. McFarlane BM, McSorley CG, McFarlane IG et al (1985) A radioimmunoassay for detection of circulating antibodies reacting with the hepatic asialoglycoprotein receptor protein. J Immunol Methods 77: 219-228.
53. McFarlane IG, Hegarty JE, McSorley CG et al (1984) Antibodies to liver-specific protein predict outcome of treatment withdrawal in autoimmune chronic active hepatitis. Lancet 2: 954-956.
54. McFarlane BM, McSorley CG, Vergani D et al (1986) Serum autoantibodies reacting with the hepatic asialoglycoprotein receptor protein (hepatic lectin) in acute and chronic liver disorders. J Hepatol 3: 196-205.
55. McFarlane BM, Sipos J, Gove CD et al (1990) Antibodies against the hepatic asialoglycoprotein receptor perfused in situ preferentially attach to periportal liver cells in the rat. Hepatology 11: 408-415.
56. Treichel U, Gerken G, Rossol S et al (1993) Autoantibodies against the human asialoglycoprotein receptor: effects of therapy in autoimmune and virus-induced chronic active hepatitis. J Hepatol 19: 55-63.
57. Treichel U, McFarlane BM, Seki T et al (1994) Demographics of anti-asialoglycoprotein receptor autoantibodies in autoimmune hepatitis. Gastroenterology 107: 799-804.
58. Treichel U, Poralla T, Hess G et al (1990) Autoantibodies to human asialoglycoprotein receptor in autoimmune-type chronic hepatitis. Hepatology 11: 606-612.
59. Czaja AJ, Pfeifer KD, Decker RH et al (1996) Frequency and significance of antibodies to asialoglycoprotein receptor in type 1 autoimmune hepatitis. Dig Dis Sci 41: 1733-1740.
60. Dejica D, Treichel U, Par A et al (1997) Anti asialoglycoprotein receptor antibodies and soluble interleukin-2 receptor levels as marker for inflammation in autoimmune hepatitis. Z Gastroenterol 35: 15-21.
61. Lohse AW, Gerken G, Mohr H et al (1995) Relation between autoimmune liver diseases and viral hepatitis: clinical and serological characteristics in 859 patients. Z Gastroenterol 33: 527-533.
62. Yoshioka M, Mizuno M, Morisue Y et al (2002) Anti-asialoglycoprotein receptor autoantibodies, detected by a capture-immunoassay, are associated with autoimmune liver diseases. Acta Med Okayama 56: 99-105.
63. Bedlow AJ, Donaldson PT, McFarlane BM et al (1989) Autoreactivity to hepatocellular antigens in primary biliary cirrhosis and primary sclerosing cholangitis. J Clin Lab Immunol 30: 103-109.
64. Vento S, McFarlane BM, Vento TG et al (1988) Serial study of liver-directed autoantibodies and autoreactive T-lymphocytes in acute viral hepatitis B. J Autoimmun 1: 299-307.
65. McFarlane BM, Bridger CB, Smith HM et al (1995) Autoimmune mechanisms in chronic hepatitis B and delta virus infections. Eur J Gastroenterol Hepatol 7: 615-621.
66. Lohr H, Treichel U, Poralla T et al (1992) Liver-infiltrating T helper cells in autoimmune chronic active hepatitis stimulate the production of autoantibodies against the human asialoglycoprotein receptor in vitro. Clin Exp Immunol 88: 45-49.
67. Lohr H, Treichel U, Poralla T et al (1990) The human hepatic asialoglycoprotein receptor is a target antigen for liver-infiltrating T cells in autoimmune chronic active hepatitis and primary biliary cirrhosis. Hepatology 12: 1314-1320.
68. Hausdorf G, Roggenbuck D, Feist E et al (2009) Autoantibodies to asialoglycoprotein receptor (ASGPR) measured by a novel ELISA-revival of a disease-activity marker in autoimmune hepatitis. Clin Chim Acta 408: 19-24.
69. Poralla T, Ramadori G, Dienes HP et al (1987) Liver cell damage caused by monoclonal antibody against an organ-specific membrane antigen in vivo and in vitro. J Hepatol 4: 373-380.
70. Gonzales C, Cochrane AM, Eddleston AL et al (1979) Mechanisms responsible for antibody-dependent, cell-mediated cytotoxicity to isolated hepatocytes in chronic active hepatitis. Gut 20: 385-388.
71. Cochrane AM, Moussouros A, Thomsom AD et al (1976) Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis. Lancet 1: 441-444.
72. Hopf U, Meyer zum Buschenfelde KH, Arnold W (1976) Detection of a liver-membrane autoantibody in HBsAg-negative chronic active hepatitis. N Engl J Med 294: 578-582.
73. Meyer zum Buschenfelde KH, Treichel U, Lohr H et al (1991) Human asialoglycoprotein receptor as an autoantigen in chronic hepatitis. Immunol Res 10: 497-502.
74. Vergani D, Longhi MS, Bogdanos DP et al (2009) Autoimmune hepatitis. Semin Immunopathol 31: 421-435.
75. Wen L, Ma Y, Bogdanos DP et al (2001) Pediatric autoimmune liver diseases: the molecular basis of humoral and cellular immunity. Curr Mol Med 1: 379-389.
76. Longhi MS, Hussain MJ, Bogdanos DP et al (2007) Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2. Hepatology 46: 472-484.
77. Longhi MS, Ma Y, Bogdanos DP et al (2004) Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol 41: 31-37.
78. Longhi MS, Ma Y, Mitry RR et al (2005) Effect of CD4+CD25+regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis. J Autoimmun 25: 63-71.
79. Ma Y, Bogdanos DP, Hussain MJ et al (2006) Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2. Gastroenterology 130: 868-882.
80. Ma Y, Okamoto M, Thomas MG et al (2002) Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. Hepatology 35: 658-664.
81. Ma Y, Thomas MG, Okamoto M et al (2002) Key residues of a major cytochrome P4502D6 epitope are located on the surface of the molecule. J Immunol 169: 277-285.
82. Mullighan CG, Bogdanos DP, Vergani D et al (2006) Cytochrome P450 1A2 is a target antigen in hepatitic graft-versus-host disease. Bone Marrow Transplant 38: 703-705.
83. Vergani D, Choudhuri K, Bogdanos DP et al (2002) Pathogenesis of autoimmune hepatitis. Clin Liver Dis 6: 727-737.
84. Hintermann E, Holdener M, Bayer M et al (2011) Epitope spreading of the anti-CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model. J Autoimmun 37: 242-253.
85. Christen U, Hintermann E, Jaeckel E (2009) New animal models for autoimmune hepatitis. Semin Liver Dis 29: 262-272.
86. Werner L, Paclik D, Fritz C et al (2012) Identification of pancreatic glycoprotein 2 as an endogenous immunomodulator of innate and adaptive immune responses. J Immunol 189: 2774-2783.
87. Roggenbuck D, Hausdorf G, Martinez-Gamboa L et al (2009) Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn's disease. Gut 58: 1620-1628.
88. Bogdanos DP, Rigopoulou EI, Smyk DS et al (2011) Diagnostic value, clinical utility and pathogenic significance of reactivity to the molecular targets of Crohn's disease specific-pancreatic autoantibodies. Autoimmun Rev 11: 143-148.
89. Hajoui O, Martin S, Alvarez F (1998) Study of antigenic sites on the asialoglycoprotein receptor recognized by autoantibodies. Clin Exp Immunol 113: 339-345.
90. Treichel U, Schreiter T, Meyer zum Buschenfelde KH et al (1995) High-yield purification and characterization of human asialoglycoprotein receptor. Protein Expr Purif 6: 251-255.
91. Rigopoulou EI, Roggenbuck D, Smyk DS et al (2012) Asialoglycoprotein receptor (ASGPR) as target autoantigen in liver autoimmunity: lost and found. Autoimmun Rev.
92. Alvarez F, Berg PA, Bianchi FB et al (1999) International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31: 929-938.
93. Hennes EM, Zeniya M, Czaja AJ et al (2008) Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 48: 169-176.
94. Hajoui O, Debray D, Martin S et al (2000) Auto-antibodies to the asialoglycoprotein receptor in sera of children with auto-immune hepatitis. Eur J Pediatr 159: 310-313.
95. Gregorio GV, Portmann B, Reid F et al (1997) Autoimmune hepatitis in childhood: a 20-year experience. Hepatology 25: 541-547.
96. Johnson PJ, McFarlane IG, McFarlane BM et al (1990) Auto-immune features in patients with idiopathic chronic active hepatitis who are seronegative for conventional auto-antibodies. J Gastroenterol Hepatol 5: 244-251.
97. Bogdanos DP, Mieli-Vergani G, Vergani D (2009) Autoantibodies and their antigens in autoimmune hepatitis. Semin Liver Dis 29: 241-253.
98. Johnson PJ, McFarlane IG (1993) Meeting report: International Autoimmune Hepatitis Group. Hepatology 18: 998-1005.
99. Vergani D, Alvarez F, Bianchi FB et al (2004) Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol 41: 677-683.
100. Chantran Y, Ballot E, Johanet C (2012) Autoantibodies in autoimmune hepatitis: anti-asialoglycoprotein receptor (anti-ASGPR) antibodies. Clin Res Hepatol Gastroenterol.
101. Hilgard P, Schreiter T, Stockert RJ et al (2004) Asialoglycoprotein receptor facilitates hemolysis in patients with alcoholic liver cirrhosis. Hepatology 39: 1398-1407.
102. Husa P, Chalupa P, Stroblova H et al (2001) Autoantibodies to asialoglycoprotein receptor in chronic hepatitis C patients. Acta Virol 45: 7-11.
103. Sasaki M, Yamauchi K, Tokushige K et al (2001) Clinical significance of autoantibody to hepatocyte membrane antigen in type 1 autoimmune hepatitis. Am J Gastroenterol 96: 846-851.
104. Mytilinaiou MG, Roggenbuck D, Grammatikopoulos A et al (2011) Anti-asialoglycoprotein receptor antibody measured by ELISA is a specific marker of liver autoimmunity and mirrors disease activity in patients with autoimmune hepatitis. Hepatology 54: 919A.